Woodline Partners’s TELA Bio TELA Stock Holding History

Woodline Partners’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40,238	Closed	-$315K	–	191
2020 Q1	$315K	Sell	40,238 -188,296	-82%	-$2.54M	0.02%	136
2019 Q4	$2.96M	Buy	+228,534	New	+$2.79M	0.12%	99

Other funds holding TELA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Woodline Partners's TELA Position: Q2 2020 in Review

Woodline Partners sold out of TELA Bio (TELA) in Q2 2020, closing a stake of 40,238 shares — an estimated $315K sold.

Woodline Partners first reported a position in TELA in Q4 2019 and held it in 2 quarters. The position peaked at $2.96M in Q4 2019. 49 funds tracked by Wall St. Rank hold TELA as of Q2 2020.

Woodline Partners reported no remaining TELA Bio position as of Q2 2020 after selling out during the quarter.
Woodline Partners sold 40,238 TELA Bio shares in Q2 2020, an estimated $315K.
Woodline Partners first reported a position in TELA Bio in Q4 2019 and held it in 2 quarters.
Woodline Partners's TELA Bio position peaked at $2.96M in Q4 2019.
49 funds tracked by Wall St. Rank held TELA Bio as of Q2 2020.

Based on Woodline Partners's 13F filing for Q2 2020, filed 14 Aug 2020.